Target intelligence / Profile preview

Biological macromolecules (DNA, proteins, lipids) damaged by reactive oxygen species and lipid peroxidation products (ROS/LPO-damaged macromolecules)

Target
ROS/LPO-damaged macromolecules
Molecular classification
Other
01

Overview

Biological macromolecules, including DNA, proteins, and lipids, are the primary substrates for damage by reactive oxygen species (ROS) and lipid peroxidation products (Source: NIH/NCBI, PMC4066722). ROS such as hydroxyl radicals cause direct oxidative modifications like 8-hydroxy-2'-deoxyguanosine (8-OHdG) in DNA and carbonyl groups in proteins, which can lead to mutations and loss of protein function (Source: StatPearls, Oxidative Stress). Lipid peroxidation involves the degradation of membrane lipids, producing reactive electrophiles like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) that form covalent adducts with proteins and DNA (Source: PubMed, PMID: 24903357). Although these macromolecules are not classical therapeutic targets like receptors or enzymes, they are the critical sites of injury in neurodegenerative diseases, cardiovascular disorders, and cancer. Pharmacological strategies, such as the use of N-acetylcysteine or edaravone, focus on scavenging ROS or inhibiting lipid peroxidation to preserve the structural and functional integrity of these essential cellular components.

Other names
Oxidative stress targetsROS-modified macromoleculesLipid peroxidation adductsOxidatively modified biomoleculesTargets of oxidative injury
02

Mechanism of action

Antioxidants and radical scavengers neutralize reactive oxygen species or terminate lipid peroxidation chain reactions to prevent the covalent modification and degradation of DNA, proteins, and lipids.

03

Biological functions

Cellular homeostasisStructural integrityGenetic stabilitySignal transductionMembrane fluidity
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationAging-related diseasesIschemia-reperfusion injury
05

Safety considerations

Disruption of essential physiological redox signalingPotential pro-oxidant activity at high concentrationsPoor clinical translation of general antioxidant therapiesInterference with ROS-dependent immune responses
06

Interacting drugs

N-acetylcysteine

6 more in the full profile.

07

Biomarkers

8-hydroxy-2'-deoxyguanosine (8-OHdG)Malondialdehyde (MDA)4-hydroxynonenal (4-HNE)Protein carbonyl contentF2-isoprostanesNitrotyrosine

Beyond the preview

Go deeper on Biological macromolecules (DNA, proteins, lipids) damaged by reactive oxygen species and lipid peroxidation products (ROS/LPO-damaged macromolecules).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological macromolecules (DNA, proteins, lipids) damaged by reactive oxygen species and lipid peroxidation products (ROS/LPO-damaged macromolecules).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call